DLL3 and neoplasm: The authors found that the increased regulation of DLL3 expression was associated with an older patient age (≥64 years), a higher stage of tumor according to the International Federation of Gynecology and Obstetrics (FIGO) (OR = 2.9 for stage I/II compared to stage III/IV), a lower differentiation grade 3 (OR = 5.1 for grade 1/2 compared to grade 3), a deep invasion into the myometrium (OR = 2.2), and metastases to pelvic (OR = 12.9) and paraaortic lymph nodes (OR = 9.9) (p ≤ 0.001).